ISPE Announces Keynote Speakers for its 2026 ISPE Pharma 4.0™ and Biopharma Conference
21 September, 2026
The conference will take place 10–11 December in Berlin, Germany, and virtually.
The conference will feature three technical tracks covering digital enablement, compliant operations, and practical biopharma manufacturing transformation through Pharma 4.0™ principles.
North Bethesda, Md., 16 September 2026 – The International Society for Pharmaceutical Engineering (ISPE) has announced its keynote speakers for the 2026 ISPE Pharma 4.0™ and Biopharma Conference, set for Thursday, 10 December, through Friday, 11 December, in Berlin, Germany, and virtually.
The conference is ISPE’s first international event to integrate Pharma 4.0™ and biopharma topics into a single program. Sessions will address digital transformation and advanced manufacturing across traditional pharmaceutical operations as well as biologics, cell and gene therapies, ATMPs, and mRNA technologies.
“This year’s keynote speakers represent a unique cross-section of expertise spanning pharmaceutical engineering, bioprocess innovation, digital manufacturing, and product development. Their perspectives will help attendees better understand the technologies, strategies, and leadership approaches shaping the future of Pharma 4.0™ and biopharma,” said Lineke Pelleboer, International Program Committee Conference Co-Chair, Senior Business Developer at Bilthoven Biologicals.
ISPE has announced the following keynote speakers:
Across the conference tracks, attendees will explore practical approaches to digital transformation, from data readiness and AI enablement to smart manufacturing, compliance, and scalable biopharma operations, with real-world lessons from industry leaders.
